Peripheral lymphocyte subsets as predicting factors for molecular recurrence after imatinib discontinuation in a phase 2 imatinib discontinuation trial in patients with chronic myeloid leukemia Arthur Gomes Oliveira Braga; Katia Borgia Barbosa Pagnano; Marina Dal'Bó Pelegrini Campioni; Ana Beatriz Pascoal Lopes; Gislaine Oliveira Duarte; Konradin Metze; Irene Lorand-Metze;

Overall survival in multiple myeloma in Brazil: A cohort of 16 years Deborah Marta do Santos Oliveira; Isabela Cristina Menezes de Freitas; Wallace Mateus Prata; Isabella Zuppo Laper; Pâmela Santos Azevedo; Adriano de Paula Sabino; Marisa Yurico Itonaga; Carmino Antonio de Souza; Mariângela Leal Cherchiglia; Juliana Alvares Teodoro; Francisco de Assis Acurcio; Augusto Afonso Guerra Junior;

Leucemia Mielomonocítica Crônica (LMMC) com aparecimento simultâneo de um clone de Neoplasia Linfoproliferativa Crônica Maria Rafaela M Barbosa da Silva; Ana Paula F Dametto; Guilherme RA Mendonça; Irene Lorand-Metze;